Cross-sectional Study on Medical Attitude Towards Artificial Intelligence Use in Fibromyalgia: Insights From the Annual Thinking Lab on Fibromyalgia Syndrome (ATLAS 2024)

关于医学界对人工智能在纤维肌痛治疗中应用的态度的横断面研究:来自纤维肌痛综合征年度思维实验室(ATLAS 2024)的见解

阅读:1

Abstract

BACKGROUND: The integration of artificial intelligence (AI) in healthcare has the potential to revolutionize clinical practice, particularly in the management of complex conditions such as fibromyalgia (FM). Despite its promise, the adoption of this technology in practice faces several challenges, including limited knowledge and preparedness among healthcare professionals. AIM: To evaluate the level of knowledge before and after a workshop on AI in FM among clinicians of different disciplines. METHODS: A survey was conducted at the end of the lab. An anonymous 21-item questionnaire was administered to participants. RESULTS: This survey (n = 26) revealed that while most had extensive clinical experience and some prior exposure to AI, the majority lacked sufficient knowledge and felt unprepared to integrate AI into FM management. Post-congress, perceptions of AI improved for many, but significant barriers remained, including lack of training, resistance to change, and cost concerns. Key benefits identified were symptom monitoring and decision support. Targeted training and technical support were highlighted as essential for effective AI adoption in clinical practice. CONCLUSION: Despite a generally positive shift in perception following the congress, many doctors still feel unprepared and lack the necessary knowledge to effectively utilize AI tools. These results underscore the importance of targeted training and support to implement research and facilitate the integration of AI tools in FM and other clinical settings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。